| |
|
|
|
Harvard Bioscience Inc.  
|
|
4.06 0.02 (0%) |
04-18 13:13 |
|
Open: |
4 |
Pre close: |
4.04 |
Target:
|
4.97
|
|
High: |
4.315 |
Low: |
3.97 |
Resistance:
|
4.26
4.66
|
|
Volume: |
43,234 |
Market Cap: |
153M |
Support:
|
3.60
3.00
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.28
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
4.23  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
3.67 |
Stochastic Oscillator |
%K(14,3):
|
37.75 |
|
MA(250): |
4.52 |
%D(3): |
54.06 |
|
Average Volume(K) |
3-Month: |
12093
|
52-Week |
High:
|
6.70 |
|
10-Days: |
10980 |
Low: |
2.75 |
|
RSI |
RSI(14):
|
47.33 |
Change(%): |
-29.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.130 |
Return on Equity (ttm) |
-3.7 |
Shares Out. (M) |
37.69 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-2.1 |
Shares Float (M) |
29.94 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
2.04 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
56.4 |
% Held by Institutions |
98.00 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.940 |
EBITDA (p.s.) |
0.000 |
P/E |
31.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
186.50 |
P/BV |
2.10 |
|
Profit Margin |
0.90 |
Operating Cash Flow
(M) |
2.88 |
P/S |
46319308.00 |
|
Operating Margin |
3.96 |
Levered Free Cash Flow
(M) |
10.94 |
P/CF |
53.26 |
|
|
|
|
|
|
